Insider Trading May 15, 2026 05:22 PM

Venture Global General Counsel Sells $15 Million in Stock Following Option Exercises

Insider transactions and recent Q1 earnings report provide mixed signals for VG, with stock trading up 64% over six months.

By Leila Farooq VG

Keith D Larson, the General Counsel and Secretary of Venture Global, Inc. (VG), executed two separate sales of Class A Common Stock across May 14 and May 15, 2026, totaling approximately $15.06 million. These transactions involved him first exercising stock options and then selling all acquired shares. This insider activity occurred while the company's shares are trading at $14.23, a price that has seen an increase of roughly 64% over the preceding six months.

Venture Global General Counsel Sells $15 Million in Stock Following Option Exercises
VG

Key Points

  • Insider Selling Activity: Keith D Larson sold approximately $15.06 million worth of VG stock over two days (May 14-15, 2026) following the exercise of options.
  • Mixed Financial Signals: While VG reported a significant revenue surge attributed to strategic expansion, its Q1 EPS missed forecasts by 47.22% ($0.19 actual vs $0.36 forecast).
  • Valuation Concern: Despite the stock trading up 64% in six months and showing strong revenue growth, analysis suggests VG may be overvalued relative to its Fair Value estimate.

Insider activity involving executive holdings can provide insight into internal perceptions of valuation and corporate trajectory. Such transactions, particularly those involving significant sales by senior officers, are closely monitored by market analysts as potential indicators of confidence or risk assessment within the company’s management.

Recently, Keith D Larson, who serves as General Counsel and Secretary for Venture Global, Inc. (VG), executed substantial stock sales totaling approximately $15.06 million in Class A Common Stock over two consecutive days: May 14 and May 15, 2026. These sales were directly linked to the exercise of existing stock options.

Details of the Insider Transactions

The first day of transactions, May 14, saw Mr. Larson acquire 555,556 shares of Class A Common Stock by exercising his stock options at a rate of $0.79 per share. Following this acquisition, he sold every single one of those 555,556 shares. The sales executed on this date were conducted at a weighted average price of $13.0671 per share. Furthermore, individual transaction prices for the day ranged between $12.80 and $13.26.

On May 15, Mr. Larson repeated the pattern, acquiring an additional 555,555 shares of Class A Common Stock through the exercise of stock options, also at a cost of $0.79 per share. Like the previous day, he subsequently sold all 555,555 shares. These sales on May 15 occurred at a weighted average price of $14.0415 per share, with individual transaction prices observed ranging from $13.45 to $14.39.

In aggregate, the transactions reveal that Mr. Larson acquired a total of 1,111,111 shares through option exercises, incurring a combined cost of $877,777. He then sold this exact number of shares for a collective value approximating $15,060,331. It is noted that the stock options utilized were fully vested and exercisable, carrying an expiration date set for July 1, 2027. After completing these sales, Mr. Larson reported holding no direct Class A Common Stock in VG.

Contextualizing the Sales with Q1 Earnings

These recent stock movements occur against a backdrop of mixed company performance and strong market appreciation for VG. The company recently released its first-quarter earnings report for 2026, which contained notable elements for investors to consider.

Financially, the Q1 results showed an earnings per share (EPS) miss. VG reported an actual EPS of $0.19. This figure fell considerably short of the projected forecast of $0.36, representing a negative surprise magnitude of 47.22%. Despite this shortfall in profitability metrics, the company simultaneously demonstrated substantial growth in its revenue stream. This positive revenue trajectory has been linked by observers to VG's ongoing strategic expansion plans, suggesting that growth initiatives are playing a significant role in the overall corporate outlook.

Analyst reaction to the combined earnings and insider activity has been muted; no upgrades or downgrades were provided by analysts following the release of this period's report. The company’s continued focus on its strategic operational initiatives remains a key point of interest for investors, as these developments constitute recent updates regarding Venture Global Inc.

Valuation and Market Perception

From a valuation standpoint, the market data presents an additional layer of complexity. As VG shares currently trade at $14.23, this price reflects a remarkable gain of approximately 64% over the preceding six months. However, analysis provided by InvestingPro suggests that the stock may be significantly overvalued when compared to its calculated Fair Value estimate. Consequently, according to this specific valuation model, the stock is positioned among companies categorized on the Most Overvalued list.

The interplay between executive selling, strong revenue growth, and perceived valuation levels creates a complex picture of internal confidence versus market momentum for VG.

Risks

  • Profitability Shortfall: The significant miss on Q1 EPS ($0.19 actual vs $0.36 forecast) introduces a risk regarding the immediate profitability and operational efficiency of the company.
  • Insider Selling Pressure: The large-scale sale by an executive, even if based on pre-existing options, can signal potential internal concerns or liquidity needs that may temper future stock performance.
  • Valuation Risk: Current market pricing being flagged as 'Most Overvalued' suggests a high risk of correction if the company fails to meet heightened investor expectations.

More from Insider Trading

Insider Activity and Corporate Developments at Morningstar Highlight Valuation Concerns May 15, 2026 Director Bobbitt Sells Shares of Hilltop Holdings Amid Mixed Quarterly Results and Board Appointments May 15, 2026 Insider Activity at AMREP CORP Signals Continued Confidence Amid Mixed Analyst Reports May 15, 2026 PTC Therapeutics Executive Activity Amid Strong Q1 Earnings and Stock Valuation Concerns May 15, 2026 Insider Buying Activity and Corporate Developments at O-I Glass Point to Valuation Reassessment May 15, 2026